No not quite. This guy got on the phase 2 for 3 to 12 months who had not been on phase 1.
It was a guy in the EU applying for the phase 3 trial. Half of the people are 0 - 3 months and half 3 -12 months. I am not sure what country it was but I will try and find out. Maybe the US is different laws.Which country is this guy? I am in US but as far as I know they accept up to 3 months?
Also, is the US in phase 2? If so, then it is 0 to 3 months only. Phase 3 looks in the 3 - 12 months.
I think is phase 2 only in US.I wonder if they will start a phase 3 .Thanks for the reply ...
When do we think this will be released to buy/have it used as a treatment?
I have had T just shy of 3 months. What one would you recommend I take part in? Or should I try and go for both? Thanks. Caff
I respect the heck out of Hudson, but I have to disagree. The Autifony trials start in September, so it's just a short wait, and to me it doesn't look like AM-101 does much more than turn down the volume in those people it helps at all. AU00063, the Autifony drug, targets the hyperactive nerve channels responsible for the tinnitus quite specifically, and is aimed at getting them out of their "stuck" mode and operating properly. Myself and a number of other posters are considering trying another drug with a similar effect, Retigabine. AU00063 is supposed to be the sniper bullet compared to Retigabine's shotgun approach, and seems to be well supported by the latest theories.
Problem with signing up for AM-101 now is that it would presumably disqualify you from participating in the AU00063 trial, since they want to be sure it's their drug that is effective. I tried to sign up for AM-101 months ago, but we are so near the Autifony trial now that IMO it's worth the wait. Here in the US, we are not getting a tinnitus trial for Autifony, rather they are trying it for hearing acuity. I'm not as confident that I'll be able to get into that one, so I'm considering Retigabine. If I were anywhere in the U.K., I'd be content to wait for Autifony. They will have several sites participating, partially run through UCL, so it should be easy to get on board.
The only caveat for you may be that there is a rumor they may seek patients with under 6 months duration, not that the drug will be limited to those patients, but because it may be easier to reset them to a healthy state. We'll hopefully get the full criteria soon.
I can see both sides of the argument, but just for me, I'm much more hopeful AU00063 will be a cure. AM-101 seems destined to be consigned to an early intervention, worth trying for new cases but outclassed for sufferers with more than 3 months duration. Just my opinion, mind. YMMV.
Where did you get the info about the AUT00063 trial phase II starting in September? Do you know if it will be only in the UK, or in mainland Europe too? Cheers.
It will only be in the UK and it is scheduled to start in september. All the info is in the Autifony thread. Read the whole thread, it's worth it
Lets say you had taken part in the AM101 trial and AUT00063 proved to be successful in trials for chronic T and got FDA approval as a cure for T in year say 2016. Would the fact that you had been administered with i.t AM101 at some point, decrease your chances of AUT00063 being effective on you? Or are the Kv3 pottasium channels not affected by AM101? And therefore would AUT00063, still be effective for people with chronic T, that had had, at some point been administered AM101?
I can understand that taking part in AM101 prevents you from taking part in the AUT00063 trial. But would it also potentially make you immune to AUT00063?
I respect the heck out of Hudson, but I have to disagree. The Autifony trials start in September, so it's just a short wait, and to me it doesn't look like AM-101 does much more than turn down the volume in those people it helps at all. AU00063, the Autifony drug, targets the hyperactive nerve channels responsible for the tinnitus quite specifically, and is aimed at getting them out of their "stuck" mode and operating properly. Myself and a number of other posters are considering trying another drug with a similar effect, Retigabine. AU00063 is supposed to be the sniper bullet compared to Retigabine's shotgun approach, and seems to be well supported by the latest theories.
Problem with signing up for AM-101 now is that it would presumably disqualify you from participating in the AU00063 trial, since they want to be sure it's their drug that is effective. I tried to sign up for AM-101 months ago, but we are so near the Autifony trial now that IMO it's worth the wait. Here in the US, we are not getting a tinnitus trial for Autifony, rather they are trying it for hearing acuity. I'm not as confident that I'll be able to get into that one, so I'm considering Retigabine. If I were anywhere in the U.K., I'd be content to wait for Autifony. They will have several sites participating, partially run through UCL, so it should be easy to get on board.
The only caveat for you may be that there is a rumor they may seek patients with under 6 months duration, not that the drug will be limited to those patients, but because it may be easier to reset them to a healthy state. We'll hopefully get the full criteria soon.
I can see both sides of the argument, but just for me, I'm much more hopeful AU00063 will be a cure. AM-101 seems destined to be consigned to an early intervention, worth trying for new cases but outclassed for sufferers with more than 3 months duration. Just my opinion, mind. YMMV.
Charles Large send an email to TT user Dan where he stated that phase 2 is scheduled to start september/october this year and it will only be for UK citizens. Both this thread and the Autifony thread are so long now that people get confusedOk! Hm, I thought I did but maybe I missed that. I guess it won't be open to none UK citizens?
Lets say you had taken part in the AM101 trial and AUT00063 proved to be successful in trials for chronic T and got FDA approval as a cure for T in year say 2016. Would the fact that you had been administered with i.t AM101 at some point, decrease your chances of AUT00063 being effective on you? Or are the Kv3 pottasium channels not affected by AM101? And therefore would AUT00063, still be effective for people with chronic T, that had had, at some point been administered AM101?
I can understand that taking part in AM101 prevents you from taking part in the AUT00063 trial. But would it also potentially make you immune to AUT00063?
Quite true. The poster who says he was helped by Retigabine notes that he can still hear his tinnitus if he puts his fingers in his ears. I am certainly not planning on hitting the clubs...ever.Very few things in medicine are "cured". What is much more likely is an effective treatment. The difference there is any approach we take will most likely not completely get rid of the noise, but lessen it to a good degree. I could of course be wrong, and we'll be pleasantly surprised that it cures it in a good chunk of people.
That's perfectly fine and understandable if you prefer to try your luck out with the Autifony trial if you choose.
I would just caution people that I am highly skeptical that even the Autifony drug will be a "cure". We have had this discussion on TT many times before, and I think it's worth pointing out here too. Very few things in medicine are "cured". What is much more likely is an effective treatment. The difference there is any approach we take will most likely not completely get rid of the noise, but lessen it to a good degree. I could of course be wrong, and we'll be pleasantly surprised that it cures it in a good chunk of people.
Quite true. The poster who says he was helped by Retigabine notes that he can still hear his tinnitus if he puts his fingers in his ears. I am certainly not planning on hitting the clubs...ever.
I wasn't aware that anyone had actually tried retigabine yet. Do you have a link to these posts? Thanks
How the heck could you have missed that thread? And you're supposed to be staff here It's in the Treatment section. It's the most interesting thread on TT right now. https://www.tinnitustalk.com/threads/retigabine.5074/
Thanks Hudson. That makes sense to me.@SteveToHeal
No they haven't published any results. The results wouldn't mean much for us anyway, as the Phase I trial was a safety study tested on healthy volunteers with no tinnitus. The best data we can find for efficacy is the animal trials that were conducted by Autifony and the results released at the 2013 TRI conference by Autifony.
I also will say that I really would be surprised if taking part in the AM-101 trial would somehow make you immune to any benefit from the Aut00063 compound or DQ you from participating in a trial. Typically with trials, they want you to have had a 30 day "washout" period between trials, so they can say with a good degree of certainty that any benefit you receive from their compound was definitely from their compound, and not from some holdover effect from your previous trial you participated in.
Well, I am now on the AM-101 path. My evaluation appointment is scheduled for July 23rd.
I still would be interested to hear how folks who received the AM-101 treatment in the recent past are feeling in general, as well as how their T is doing.